Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contractubex for Scar Prevention After Second Cesarean Section
NCT02708628Completed
- Sponsor
- Suleymaniye Birth and Women's Health Education and Research Hospital
- Start
- Dec 2015
- Primary completion
- Apr 2016
- Modality
- Herbal Medicine, Dietary Supplement, Homeopathic Remedy
- Countries
- 1
01
Overview
Randomised, open-label trial of Allium cepa in cicatrix (2 arms), sponsored by Suleymaniye Birth and Women's Health Education and Research Hospital. Primary endpoints: Patient and Observer Scar Assessment Scale (Observer) at 24 weeks, Patient and Observer Scar Assessment Scale (Patient) at 24 weeks and 1 more. Started Dec 2015; status: completed.
02
Drugs
Allium cepa
03
Conditions
cicatrix
Beyond the preview
Go deeper on NCT02708628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02708628.